4
Changes in Ownership
Celldex Therapeutics, Inc. Filed Acc 0001415889-25-016230
Options or other derivatives
- EXECUTIVE VP & CSO acquired 93,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| KELER TIBOR EXECUTIVE VP & CSO | 2025-06-05 | Grant or award · Incentive Stock Option (right to buy) | +93,000 | 93,000 | D | ||
Loading xslF345X05/form4-06092025_080623.xml…